Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988388 · ClinicalTrials.gov registry record
Lung Tissue Research Consortium
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 247
- Enrollment target
NCT02988388 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 247 participants.
The verdict
NCT02988388 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 247 participants
- Enrollment target
Study Summary
The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.
Interventions
- PROCEDURE Lung biopsy/lobectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2017-02-23 |
| Est. Completion | 2019-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02988388
The ClinicalTrials.gov registry entry for NCT02988388 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lung biopsy/lobectomy is the first listed.
NCT02988388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02988388 about?
NCT02988388 is a clinical study titled "Lung Tissue Research Consortium". The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate ...
What is the current status of trial NCT02988388?
This trial is currently completed. The enrollment target is 247 participants. The study started on 2017-02-23. Estimated completion is 2019-02-21.
What interventions are being tested in trial NCT02988388?
The interventions under investigation include: Lung biopsy/lobectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02988388?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.